2023-10-19 05:24:02
GÖTTINGEN (dpa-AFX) – Laboratory and pharmaceutical supplier Sartorius is facing falling profits due to continued investment sluggishness among its customers. Over the first nine months, profit fell by almost two thirds to almost 197 million euros, the Dax group announced on Thursday in Gottingen.
Last week, management had already lowered its forecasts for the current year, in particular because the destocking in customer branches continues longer than expected. Despite the first signs of recovery, the hoped-for recovery has been postponed, explains the group. At the height of the Corona pandemic, many customers had replenished their stocks for fear of delivery problems and are therefore stocked up. During the first three quarters, Sartorius’ order intake fell by almost 30% to 2.2 billion euros group-wide./tav/stk
1697699798
#Sartorius #supplier #laboratories #pharmaceutical #products #sees #profits #fall #October
